As of 2024-12-14, the Relative Valuation of Edwards Lifesciences Corp (EW) is 176.78 USD. This relative valuation is based on P/E multiples. With the latest stock price at 73.32 USD, the upside of Edwards Lifesciences Corp based on Relative Valuation is 141.1%.
The range of the Relative Valuation is 71.08 - 314.07 USD.
| Range | Selected | |
| Trailing P/E multiples | 33.7x - 44.5x | 39.8x |
| Forward P/E multiples | 29.8x - 34.6x | 30.7x |
| Fair Price | 71.08 - 314.07 | 176.78 |
| Upside | -3.1% - 328.4% | 141.1% |
| Date | P/E |
| 2024-12-13 | 10.40 |
| 2024-12-12 | 10.49 |
| 2024-12-11 | 10.47 |
| 2024-12-10 | 10.41 |
| 2024-12-09 | 10.05 |
| 2024-12-06 | 10.14 |
| 2024-12-05 | 10.27 |
| 2024-12-04 | 10.52 |
| 2024-12-03 | 9.96 |
| 2024-12-02 | 10.00 |
| 2024-11-29 | 10.12 |
| 2024-11-27 | 10.22 |
| 2024-11-26 | 10.15 |
| 2024-11-25 | 10.11 |
| 2024-11-22 | 10.00 |
| 2024-11-21 | 9.98 |
| 2024-11-20 | 9.86 |
| 2024-11-19 | 9.96 |
| 2024-11-18 | 9.91 |
| 2024-11-15 | 9.61 |
| 2024-11-14 | 9.38 |
| 2024-11-13 | 9.43 |
| 2024-11-12 | 9.33 |
| 2024-11-11 | 9.46 |
| 2024-11-08 | 9.39 |
| 2024-11-07 | 9.34 |
| 2024-11-06 | 9.32 |
| 2024-11-05 | 9.46 |
| 2024-11-04 | 9.43 |
| 2024-11-01 | 9.58 |
| 2024-10-31 | 9.50 |
| 2024-10-30 | 9.73 |
| 2024-10-29 | 9.84 |
| 2024-10-28 | 9.72 |
| 2024-10-25 | 9.84 |
| 2024-10-24 | 9.98 |
| 2024-10-23 | 10.01 |
| 2024-10-22 | 9.82 |
| 2024-10-21 | 9.93 |
| 2024-10-18 | 9.97 |
| 2024-10-17 | 9.71 |
| 2024-10-16 | 9.69 |
| 2024-10-15 | 9.77 |
| 2024-10-14 | 9.87 |
| 2024-10-11 | 9.66 |
| 2024-10-10 | 9.68 |
| 2024-10-09 | 9.65 |
| 2024-10-08 | 9.72 |
| 2024-10-07 | 9.15 |
| 2024-10-04 | 9.29 |